Literature DB >> 10089398

Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution.

D K Worthylake1, H Wang, S Yoo, W I Sundquist, C P Hill.   

Abstract

The human immunodeficiency virus type I (HIV-1) capsid protein is initially synthesized as the central domain of the Gag polyprotein, and is subsequently proteolytically processed into a discrete 231-amino-acid protein that forms the distinctive conical core of the mature virus. The crystal structures of two proteins that span the C-terminal domain of the capsid are reported here: one encompassing residues 146-231 (CA146-231) and the other extending to include the 14-residue p2 domain of Gag (CA146-p2). The isomorphous CA146-231 and CA146-p2 structures were determined by molecular replacement and have been refined at 2.6 A resolution to R factors of 22.3 and 20.7% (Rfree = 28.1 and 27.5%), respectively. The ordered domains comprise residues 148-219 for CA146-231 and 148-218 for CA146-p2, and their refined structures are essentially identical. The proteins are composed of a 310 helix followed by an extended strand and four alpha-helices. A crystallographic twofold generates a dimer that is stabilized by parallel packing of an alpha-helix 2 across the dimer interface and by packing of the 310 helix into a groove created by alpha-helices 2 and 3 of the partner molecule. CA146-231 and CA146-p2 dimerize with the full affinity of the intact capsid protein, and their structures therefore reveal the essential dimer interface of the HIV-1 capsid.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10089398     DOI: 10.1107/S0907444998007689

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  128 in total

1.  Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli.

Authors:  Milan V Nermut; Patrick Bron; Daniel Thomas; Michaela Rumlova; Tomas Ruml; Eric Hunter
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  An improved hydrogen bond potential: impact on medium resolution protein structures.

Authors:  Felcy Fabiola; Richard Bertram; Andrei Korostelev; Michael S Chapman
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

3.  Structural organization of authentic, mature HIV-1 virions and cores.

Authors:  John A G Briggs; Thomas Wilk; Reinhold Welker; Hans-Georg Kräusslich; Stephen D Fuller
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

4.  Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro.

Authors:  Jason Lanman; Jennifer Sexton; Michael Sakalian; Peter E Prevelige
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

5.  Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly.

Authors:  Barbie K Ganser; Anchi Cheng; Wesley I Sundquist; Mark Yeager
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

6.  Functional surfaces of the human immunodeficiency virus type 1 capsid protein.

Authors:  Uta K von Schwedler; Kirsten M Stray; Jennifer E Garrus; Wesley I Sundquist
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Flexibility in the P2 domain of the HIV-1 Gag polyprotein.

Authors:  John L Newman; Eric W Butcher; Dipti T Patel; Yelena Mikhaylenko; Michael F Summers
Journal:  Protein Sci       Date:  2004-07-06       Impact factor: 6.725

8.  Limitations of peptide retro-inverso isomerization in molecular mimicry.

Authors:  Chong Li; Marzena Pazgier; Jing Li; Changqing Li; Min Liu; Guozhang Zou; Zhenyu Li; Jiandong Chen; Sergey G Tarasov; Wei-Yue Lu; Wuyuan Lu
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

Review 9.  Nucleic acid chaperone activity of retroviral Gag proteins.

Authors:  Alan Rein
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

10.  Hydrogen/deuterium exchange analysis of HIV-1 capsid assembly and maturation.

Authors:  Eric B Monroe; Sebyung Kang; Sampson K Kyere; Rui Li; Peter E Prevelige
Journal:  Structure       Date:  2010-11-10       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.